We are live on ! Find out more
ECM

ExodusPoint Capital Management Portfolio holdings

AUM $12.6B
1-Year Est. Return 30.13%
This Fund
S&P 500
This Quarter Est. Return
+7.87%
1 Year Est. Return
+30.13%
3 Year Est. Return
+85.63%
5 Year Est. Return
+104.04%
10 Year Est. Return
AUM
$9.04B
AUM Growth
+$2.19B
Cap. Flow
+$1.88B
Cap. Flow %
20.78%
Top 10 Hldgs %
34.88%
Holding
3,092
New
1,032
Increased
581
Reduced
587
Closed
820

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$435M
2
AMZN icon
Amazon
AMZN
+$334M
3
MRNA icon
Moderna
MRNA
+$53.9M
4
LIN icon
Linde
LIN
+$44.2M
5
DTE icon
DTE Energy
DTE
+$43.5M

Sector Composition

Rank Sector Weight
1 Technology 15.26%
2 Consumer Discretionary 10.36%
3 Financials 6.9%
4 Industrials 6.78%
5 Healthcare 5.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FENC icon
2101
Fennec Pharmaceuticals
FENC
$379M
$125K ﹤0.01%
+17,115
New +$114K
SBS icon
2102
Sabesp
SBS
$18.5B
$125K ﹤0.01%
+87,202
New +$130K
CBAY
2103
DELISTED
Cymabay Therapeutics
CBAY
$125K ﹤0.01%
28,719
+10,980
+62% +$48.7K
APTO
2104
DELISTED
Aptose Biosciences, Inc.
APTO
$123K ﹤0.01%
+82
New +$179K
MRKR icon
2105
Marker Therapeutics
MRKR
$18.7M
$122K ﹤0.01%
4,376
+3,298
+306% +$86.8K
BKSY icon
2106
BlackSky Technology
BKSY
$1.2B
$121K ﹤0.01%
+1,516
New +$121K
RITM icon
2107
Rithm Capital
RITM
$5.63B
$121K ﹤0.01%
+11,442
New +$122K
IMBI
2108
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$121K ﹤0.01%
+15,034
New +$122K
EYPT icon
2109
EyePoint Inc
EYPT
$1.18B
$120K ﹤0.01%
13,400
-39,156
-75% -$376K
MBIO icon
2110
Mustang Bio
MBIO
$4.55M
$120K ﹤0.01%
48
+4
+9% +$9.8K
GRTS
2111
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$120K ﹤0.01%
13,093
-2,800
-18% -$25.9K
HBIO icon
2112
Harvard Bioscience
HBIO
$28M
$119K ﹤0.01%
+1,426
New +$101K
ONDS icon
2113
Ondas Inc
ONDS
$5.25B
$119K ﹤0.01%
15,004
-1,596
-10% -$12.5K
MTEM
2114
DELISTED
Molecular Templates, Inc.
MTEM
$119K ﹤0.01%
1,018
-249
-20% -$32.6K
SLDB icon
2115
Solid Biosciences
SLDB
$916M
$118K ﹤0.01%
2,146
+592
+38% +$39.1K
TCDA
2116
DELISTED
Tricida, Inc. Common Stock
TCDA
$118K ﹤0.01%
+27,220
New +$130K
NYMX
2117
DELISTED
Nymox Pharmaceutical Corp
NYMX
$117K ﹤0.01%
+73,781
New +$137K
AEI icon
2118
Alset
AEI
$42.4M
$116K ﹤0.01%
+1,017
New +$143K
AFMD
2119
DELISTED
Affimed
AFMD
$116K ﹤0.01%
+1,361
New +$124K
OLN icon
2120
PUT
Olin
OLN
$2.11B
$116K ﹤0.01%
+2,500
New +$113K
XAIR icon
2121
Beyond Air
XAIR
$3.75M
$116K ﹤0.01%
+45
New +$98.5K
ALT icon
2122
Altimmune
ALT
$589M
$115K ﹤0.01%
11,641
-65,007
-85% -$889K
SCPS
2123
DELISTED
Scopus BioPharma Inc. Common Stock
SCPS
$115K ﹤0.01%
+16,069
New +$114K
CHNG
2124
CALL
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$115K ﹤0.01%
+5,000
New +$115K
UONE icon
2125
Urban One Class A
UONE
$23.6M
$113K ﹤0.01%
+1,305
New +$108K

Similar funds

ExodusPoint Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, ExodusPoint Capital Management held 3,092 positions worth $9.04B, up 32% from $6.86B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

ExodusPoint Capital Management deployed $1.88B of net new capital in Q2 2021, opening 1,032 new positions and adding to 581 existing holdings. Its largest new stake was Linde: 151,692 shares worth $43.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $63.6M trimmed.

  • ExodusPoint Capital Management's largest Q2 2021 buy was Linde: 151,692 shares worth $43.9M.
  • ExodusPoint Capital Management added most to Microsoft in Q2 2021, an estimated $435M increase.
  • ExodusPoint Capital Management's biggest Q2 2021 reduction was iShares Russell 1000 Value ETF, cutting an estimated $63.6M.
  • ExodusPoint Capital Management fully exited Charles River Laboratories in Q2 2021, selling an estimated $27.9M.
  • ExodusPoint Capital Management's ten largest holdings make up 35% of its $9.04B portfolio in Q2 2021.
  • ExodusPoint Capital Management opened 1,032 new positions and closed 820 in Q2 2021.
  • ExodusPoint Capital Management's portfolio value rose 32% quarter-over-quarter to $9.04B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.